Dupilumab De-escalation in Pediatric Atopic Dermatitis
Dupilumab De-escalation in Pediatric Atopic Dermatitis
Recruiting · NCT06116526 · Registry updated 2026-04-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dupilumab De-escalation in Pediatric Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 4 | 2026-04-20 | NCT06116526 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Doris Duke Charitable Foundation | 18 |
| Johns Hopkins University | 579 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins Univerisity | Baltimore | United States | 1 |